FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT...
Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) ("Brooklyn"), a biopharmaceutical company focused on exploring the role that...
Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) ("Brooklyn" or “the Company”), a biopharmaceutical company focused on exploring the role...
Shares of Brooklyn ImmunoTherapeutics to commence trading on the NYSE American on March 26, 2021 under the new ticker symbol “BTX” Immediately...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC...
FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...
FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.